Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseMarc S. Sabatine, Terje R. Pedersen, Robert P. Giugliano et al.|New England Journal of Medicine|2017Cited by 6k
2016 ESC/EAS Guidelines for the Management of DyslipidaemiasAlberico L. Catapano, José Luis Zamorano, Ian Graham et al.|European Heart Journal|2016Cited by 3.2k
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic StenosisAnne B. Rossebø, Ronnie Willenheimer, Kristian Wachtell et al.|New England Journal of Medicine|2008Cited by 1.6k
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsS. Matthijs Boekholdt, John J.P. Kastelein, Benoît J. Arsenault et al.|JAMA|2012Cited by 800
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery DiseaseMarc P. Bonaca, Marc S. Sabatine, Patrice Nault et al.|Circulation|2017Cited by 754